1MedicalKnowledge.COM - Built by Doctors for the people.
1MedicalKnowledge.COM was founded
to bring affordable and professional medical advice to the internet.
All 1MedicalKnowledge.COM physicians are real medical doctors (MDs) with a valid
U.S. medical license. So you know your medical advice is coming from the best
possible source--a medical doctor with all the training and experience you would
find if you were to visit a family doctor in the United States.
This site was constructed by a physician who
wanted too assist those people that don’t have the luxury of having health
insurance but desperately need too speak to a physician about certain health
issues that may require immediate attention. This physician also wanted to assist those patients that don’t have the time or
desire to make appointments and then sit in a waiting room for a physician that
may be more interested in what type of insurance carrier you have rather than what you
may actually have. And God help you if you have the need to ask a question or
seek detailed medical advice after 12 o’ clock on a Wednesday or after five on a
Friday. 1MedicalKnowledge.COM is here to serve you 24 hours a day, 7 days a week.
Dr. Aaron Cusimano, BSsc., MS, MD.
1MedicalKnowledge.COM's lead physician is Dr. Aaron Cusimano.
References:
MEDICAL/SCIENTIFIC SKILLS:
Charted and researched patients medical records and histories.
Second opinion research analysis.
Provided balanced scientific and technical drug with pathology information to peers and staff.
Provided clinical analysis and synthesis of literature.
Medical and scientific resource for medical community in neurological pathology.
Developed and published literature for dietary concerns of Oncology patients.
Delivered quality technical medical education presentations.
Performed pharmaceutical research for varied body systems.
Developed collegial peer-to-peer relationships with therapeutic areas of pharmaceutical industry.
Directed research physician team for cause effect analysis.
Observed and reported serious adverse events (SAE), to peers and pharmaceutical staff.
Reported SAE to fellow physicians and Federal Drug Administration.
Ranked “Outstanding” in all therapeutic and clinical areas of Internal Medicine.
Academic medical program taught with full syllabus.
EDUCATION:
Spartan Health Sciences University Medical School, www.spartanmed.edu. Medical Doctorate Degree.
Tulane University Medical School, www.somtulane.edu. Master of Science Program, Biochemistry.
The George Washington University, www.gwu.edu. Bachelor of Science Degree, Biological Science.
Florida State University, www.fsu.edu. Bachelor of Arts Degrees History, Psychology.
INTERNSHIPS:
Southwest Medical Center, 505 Fairburn Road, Southwest, Atlanta, Georgia 30331.
Atlanta Medical Center, 303 Parkway Drive, Northwest, Atlanta, Georgia 30331.
CERTIFICATIONS:
Medical Doctorate World Health Organization.
Florida Medical Board.
Josef Silny & Associates Science and Medical Evaluations.
Florida Teacher Certification.
PUBLICATIONS:
Delcal, Copyright Library of Congress: TXU 420-090.
Killing Foods, Copyright pending Fall 2007.
RESEARCH:
INTERNATIONAL INDEPENDENT TRIAL ON ADVERSE EFFECT OF PARKINSON DISEASE AND RESTLESS LEG SYNDROME MEDICATIONS. COMPANY AND PROTOCOL NON-DISCLOSED.
INTERNATIONAL MULTICENTER LARGE SIMPLE TRIAL TO COMPARE CARDIOVASCULAR SAFETY AND ZIPRASIDONE AND OLANZAPINE. Protocol number: A1281062. Sponsor Pfizer Inc., 235 East 42nd. Street, New York, New York 10017-5735.
RANDOMIZED DOUBLE BLIND DOSE RESPONSE STUDY TO EVALUATE SAFETY AND CLINICAL BACTERIOLOGIC EFFICACY OF RIFALAZIL COMPARED WITH AZITHROMMYCIN FOR TREATMENT OF NON-GONOCOCIAL URETHRITIS IN MALES. Protocol number ABI-1648-010. Sponsor ActivBiotics, Inc., 128 Spring Street, Lexington. MA. 02421.
EFFICACY STUDY OF TAK-375 IN ELDERLY SUBJECTS WITH INSOMNIA. Protocol number 01-02-TL-375-025. Sponsor Takeda Pharmaceuticals North America, Inc. 475 Half Day Road, Suite 500, Lincolnshire, IL. 60069.
PLACEBO CONTROLLED COMPARISION OF THE EFFICACY AND SAFETY OF PULMICORT TURBUHALER WITH INHALED STEROIDS. Study core number SD-004-0620. Sponsor AstraZeneca LP. 1800 Concord Pike, Wilmington, DE. 19850.
RANDOMNIZED DOUBLE BLIND STUDY, COMPARATOR CONTROLLED STUDY OF PIOGLITAZONE HCL VS. GLYBURIDE IN TYPE II DIABETES MELLITUS AND MILD TO MODERATE CONGESTIVE HEART FAILURE SUBJECTS. Protocol number 01-00-TL-OPI-504. Sponsor Takeda Pharmaceuticals North America, Inc., 475 Half Day Road, Suite 500, Lincolnshire, IL. 60069.
1MedicalKnowledge.COM was founded
to bring affordable and professional medical advice to the internet.
